SYNTHOS RESEARCH

CenterPoint Energy CNP

Utilities · Diversified Utilities · Synthos Deep Dive · 2026-07-03

$44.61
Watch
Risk 5Growth 6Exponential 4Fair value $46 $36–$56

At a glance

VerdictWatch — systematic Synthos tier
Price (2026-07-02)$44.61 · market cap ~$29.2B
Synthos scores (0–10)Downside Risk 5 · Growth Quality 6 · Exponential Potential 4
Synthos fair value (base case)~$46+3% · full range $36 (bear) – $56 (bull)
Street consensus$44.63 (high $50 / low $37; 0 Strong Buy · 13 Buy · 17 Hold · 1 Sell → "Hold") — context, not our anchor
Valuation27× trailing GAAP EPS · ~23× FY26E · ~21× FY27E · ~17× FY30E · EV/S 5.7× · EV/EBITDA 13.9×
Exponential Potential4/10 · Low-Moderate — ~8% forward EPS CAGR; Houston's 8 GW of data-center load by 2029 is a genuine accelerant, but a regulated $29B utility structurally can't multibag
TechnicalsMild uptrend — $44.61, −1.0% off 52-wk high, above 50/200-DMA, RSI 67, +22% 12-mo (SPY +21%)
ConvictionLow — 0 expert voices, 0 KB claims. This is a data-and-model call, transparently so
Position sizingDefensive income sleeve, ~1–3% if bought on a pullback; not a conviction position here
Next catalyst2026-07-23 Q2'26 earnings (Street EPS $0.38)
Single biggest riskA rich multiple + 6.3× net-debt/EBITDA leaves no margin if rate cases, interest rates, or the load ramp disappoint

One-line thesis. CenterPoint is a well-run, Houston-centred regulated electric-and-gas utility riding a genuinely unusual tailwind — 12.2 GW of firmly committed industrial load and 8 GW of data-center demand to be energized by 2029 — but at 27× trailing earnings for ~8% growth and a Street target essentially at the current price, the stock already reflects the good news; we would own it on weakness, not here.

◆ Synthos call — Watch CNP is a business we want at a price we don't have — it becomes a Buy below ~$40; until then, do nothing.
Downside Risk (lower = safer)
5/10 · Moderate
Low beta (0.46) & regulated cash flows, but 6.3× net-debt/EBITDA and 27× earnings for ~8% growth.
Growth Quality
6/10 · High
Steady ~8% EPS CAGR, regulated ROE, but negative FCF as capex outruns operating cash.
Exponential Potential
4/10 · Moderate
Houston data-center load (8 GW by 2029) is a real accelerant — but a $29B regulated utility can't multibag.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

In plain English

CenterPoint is the company that delivers electricity and natural gas to about 2.7 million homes and businesses, mostly around Houston, Texas. It is a regulated utility — a government commission sets the prices it can charge, which makes its profits steady and boring in the good sense: people pay their power bills in booms and recessions alike.

The interesting twist: Houston is filling up with data centers (the giant computer warehouses that run AI and the internet), and CenterPoint has already signed up a huge amount of new power demand — enough that its sales base should grow faster than a typical sleepy utility.

The catch: the stock is not cheap. You're paying about 27 dollars for every dollar of yearly profit, which is a full price for a company growing profits only about 8% a year. Wall Street's own price target is basically where the stock trades today. So our verdict is Watch — a good business, but wait for a better price.

Here's what our three scores mean in everyday terms:

The one big worry: CenterPoint borrows heavily to build, so if interest rates stay high or regulators are stingy in the next rate case, both profits and the dividend get squeezed at a price that already assumes things go well.


Price & moving averages 12 months · 50 & 200-day averages · 52-week range

3336394346Jul '25Sep '25Nov '25Feb '26Apr '26Jul '2652w hi $45Price 4550-DMA 43200-DMA 4152w lo $36

Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

3437404346Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26Price 4520-day avg 43

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

705030Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26RSI 60.8

Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 61.

MACD 12 / 26 / 9 · trend & momentum

0Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26MACD 0.5signal 0.4

Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLU (sector)), set to 100 a year ago

98105113120128Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26CNP 125S&P 500 120XLU (sector) 113

Solid = CNP · dashed = S&P 500 · dotted = XLU (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

0371014$9BFY23EPS $2$9BFY24EPS $2$9BFY25EPS $2$10BFY26EEPS $2$10BFY27EEPS $2$11BFY28EEPS $2$12BFY29EEPS $2$12BFY30EEPS $3

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$44.61
Market cap$29B
P/E trailing
P/E FY26E / FY27E23× / 21×
EV / Sales5.7×
EV / EBITDA13.9×
Gross margin41.3%
Net margin11.4%
Dividend yield2.02%
Beta0.461
52-wk range$36 – $45
RSI(14)67
50 / 200-DMA$43 / $41
12-mo return+22% (SPY +21%)
Street target$45 ($37–$50)
Analyst grades13 Buy · 17 Hold · 1 Sell
FMP ratingC+
Next earnings2026-08-05

What the experts actually said 0 traceable claims on CNP · showing the highest-conviction voices

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

1. What it is

CenterPoint Energy (NYSE: CNP) is a ~160-year-old regulated public-utility holding company headquartered in Houston, Texas, operating through two segments: Electric Transmission & Distribution and Natural Gas. It serves roughly 2.7 million metered customers across Texas and several other states (Indiana, Ohio, Minnesota, and others), owning ~239 substations, ~100,000 linear miles of gas mains, and the poles-and-wires that carry power into Greater Houston. Fiscal year ends December 31. It is a "wires-and-pipes" utility — it earns a regulator-approved return on the capital it invests in infrastructure, not on commodity prices.

Revenue mix (FY2025, from filings):

The strategic story management keeps returning to (§9) is a capital-plan-driven growth utility: a large, multi-year capex program (rebuilding Houston's grid for resiliency after the 2024 storm season, plus connecting new large loads) that grows the regulated rate base — and with it, earnings — at a targeted high-single-digit rate.

2. The expert thesis — why the panel is bullish (traceable)

There is no expert coverage of CNP in the Synthos knowledge base. total_claims = 0, net_bullish_voices = 0. No independent voice in our panel has published a traceable claim on this name.

That means this note carries no conviction-track signal — we cannot cite a single claim_id because none exists, and House Standard forbids fabricating one. The verdict below is entirely fundamentals- and quant-driven: it rests on the FMP financials, analyst consensus estimates, management's own SEC-filed guidance (half-weighted, §9), and the Synthos scoring model. Where a conviction name like our flagships leans on a dozen reconciled expert voices, CNP leans only on the numbers. Read the scores and cases below as a disciplined quant read, not an informed-insider call.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score0–10The read
Downside Risk (lower = safer)5 · ModerateBeta 0.46 and regulated, recession-resistant cash flows are genuinely defensive, but net-debt/EBITDA 6.3× (high even for a utility) and 27× trailing EPS for ~8% growth leave little cushion; interest-rate and rate-case sensitivity are the swing factors.
Growth Quality6 · Decent~8% forward EPS CAGR, regulated ROE ~9.6%, a credible rate-base growth plan and real load tailwind — but returns on capital are utility-modest (ROIC ~4%) and FCF is negative as capex (~$4.9B) runs at ~2× operating cash flow.
Exponential Potential4 · Low-ModerateThe Houston data-center ramp (8 GW by 2029, 3.5 GW under construction) is a real second-derivative kicker rare for a utility, but regulation caps the growth rate and a $29B rate-base-bound model cannot multibag.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.

CaseKey assumptionsFair value
BullData-center load energizes on/ahead of schedule; constructive Texas rate cases; interest costs ease. FY27E EPS beats to ~$2.15 (vs $2.08 cons); market pays a premium ~26× for accelerating rate-base growth.~$56 (+25%)
Base (our anchor)Guidance roughly holds — FY26 non-GAAP EPS ~$1.90 growing ~8%/yr; a steady regulated compounder earns a ~24× forward multiple on ~$1.95 blended forward EPS.~$46 (+3%)
BearRate-case setbacks, storm-cost disallowance, or higher-for-longer rates squeeze the levered balance sheet; multiple de-rates to peer-average ~17× on ~$2.05 EPS.~$36 (−19%)

Synthos fair value = the base case, ~$46 (+3%), with the full $36–$56 span as the honest range. Our base sits essentially on top of the Street's $44.63 consensus — which is itself telling: at this price the market has fairly priced the growth story, and there is no obvious mispricing to exploit. Our bear ($36) roughly matches the Street's $37 low; our bull ($56) exceeds the Street's $50 high because we give more credit to the data-center optionality if it fully lands. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable, regulated returns on capital) from exponentials (accelerating multi-baggers-from-here). CNP is a steady regulated compounder with a modestly accelerating load profile — not an exponential:

Exponential Potential: Low-Moderate (4/10). Own it for durable high-single-digit regulated compounding plus a real, if bounded, data-center tailwind — not for a multibagger. A small-cap accelerating name with these growth-acceleration dynamics would score 7–8; regulation and scale cap CNP at 4.

5. Financials (real numbers — FMP annual/quarterly)

6. Valuation — priced in or room?

CNP is not cheap and not egregiously expensive — it's fairly priced, which is precisely why the verdict is Watch. On trailing GAAP EPS it trades at 27×; on forward consensus the multiple compresses to ~23× (FY26E $1.91) → ~21× (FY27E $2.08) → ~17× (FY30E $2.67) as EPS grinds higher at ~8%. EV/EBITDA is 13.9× and EV/sales 5.7× — both toward the upper end of the regulated-utility band, reflecting the market's willingness to pay up for the Houston load story. The PEG (~2.9× TTM) confirms you're paying a premium-to-growth price. Street targets (context): consensus $44.63 (essentially the current price), high $50, low $37; grades skew Hold (13 Buy / 17 Hold / 1 Sell), and FMP's letter rating is C+ (overall score 2/5, weak DCF and debt-to-equity sub-scores). Our ~$46 base fair value lands on the consensus — there is no obvious margin of safety at $44.61. A fair-price hold; buy the dips, not the current print.

7. Technicals (computed from EOD price history)

8. Moat & competitive position

CenterPoint's moat is the classic regulated-utility one: a legal, franchised monopoly over electric and gas delivery in its service territories. Customers cannot choose another wires provider, demand is inelastic (people need power and heat), and the regulator guarantees a return on prudently invested capital. The durability is high; the ceiling is also fixed — the same regulation that protects the franchise caps the return. The differentiator versus a sleepier peer is location: Greater Houston's industrial and data-center load growth gives CenterPoint an above-average rate-base growth runway. The strategic gas-LDC divestitures (Louisiana/Mississippi done, Ohio announced) sharpen the focus on the higher-growth Texas electric franchise.

Peer set (regulated utilities, market cap): Ameren $31.8B, DTE Energy $32.0B, Atmos Energy $29.5B, Fortis $29.5B, American Water Works $26.7B, FirstEnergy $28.1B, PPL $27.8B — a tight cluster of ~$27–32B regulated utilities, plus the much larger Southern Company $110B. CNP sits mid-pack on size; its edge is the Houston growth tilt, and it commands a similar-to-slightly-premium multiple to reflect it. It is not the cheapest nor the fastest-growing in the group.

9. Management, capital allocation & guidance

10. Catalysts & what to watch

Thesis tripwires (what would change the call): a cut or downward revision to the 8% EPS growth guide; an adverse rate-case or storm-cost disallowance; net-debt/EBITDA drifting further above ~6.5×; or a data-center load delay that pushes out the rate-base ramp.

11. Key risks

12. Verdict, position sizing & monitoring

Watch. CenterPoint is a genuinely well-run regulated utility with a rare and real growth kicker — Houston's data-center and industrial load boom (12.2 GW committed, 8 GW to energize by 2029) supporting above-peer ~8% EPS growth. But the market already knows this: at $44.61 the stock trades at 27× trailing earnings, the Street's consensus target ($44.63) sits essentially on the current price, and our own base-case fair value (~$46) implies only ~3% upside. With negative free cash flow, 6.3× net-debt/EBITDA, and no expert-panel signal, there is no edge to press at this price.


Provenance & disclosures